alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### F. W. Woolworth Company *v.*United States

No. 8069.

Entered at Baltimore, Md.

Entry No. 2170.

(Decided on rehearing [Reap. Dec. 8032] December 11, 1951)

*500
      *Sharretis, Ilillis & Paley (Howard C. Carter*of counsel) for the plaintiff.

*Charles J. Wagner,*Acting Assistant Attorney General *(Charles J. Miville,*special attorney), for the defendant.

Olivee, Chief Judge:

This appeal for reappraisement has been submitted for decision upon the following stipulation of counsel for the parties hereto:

> IT IS HEREBY STIPULATED AND AGREED, by and between counsel, subject to the approval of the court, that the judgment and order of the court dated August 7, 1951 in the above entitled cause be vacated and set aside and that the stipulation filed June 8, 1951 be withdrawn.

> IT IS FURTHER STIPULATED AND AGREED that the value or price at the time of exportation of the merchandise to the United States, at which such or similar merchandise was freely offered for sale to all purchasers in the principal markets of Belgium, for consumption in Belgium, in the usual wholesale quantities and in the ordinary course of trade, including the cost of all containers and coverings of whatever nature, and all other costs, charges, and expenses incident to placing the merchandise in condition, packed, ready for shipment to the United States was the invoice unit prices, including carriage to Antwerp, cartons and packing and labor in packing, plus 4)4% transmission tax, and that there was no higher export value.

> IT IS FURTHER STIPULATED AND AGREED that this appeal be resubmitted on this stipulation.

On the agreed facts I find the foreign value, as that value is defined in section 402 (c) of the Tariff Act of 1930, as amended by the Customs Administrative Act of 1938, to be the proper basis for the determination of the value of the merchandise here involved, and that such values were the invoice unit prices, including carriage to Antwerp, cartons and packing, and labor in packing, plus 4% per centum transmission tax.

Judgment will be rendered accordingly.
Before the First Division,

February 7, 1941

No. 45351.

#### Petition 5908-R of Modern Novelty Manufacturing Co. (Pittsburgh).

Opinion by

Brown, J.

It appeared that the importer made a full disclosure before entry of all its information and that there was no intention to defraud or deceive. The.petition was therefore granted.
EXHIBIT 32.b

CERTIFICATION PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Morgan Beaumont, Inc. (the “Company”) on Form 10-QSB for the period ended March 31, 2006, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Theodore Misiewicz, in my capacity as Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
| Date: May 22, 2006 | */s/ Theodore Misiewicz*

Theodore Misiewicz, Chief Financial Officer** |
|--------------------|-------------------------------------------------------------------------|
exv10w15



 






Exhibit 10.15




ALLONGE

(Term Revolving Note)




     THIS ALLONGE is made and entered into as of the 19th day of October, 2007, by and
between US BIO ALBERT CITY, LLC, an Iowa limited liability company (“Borrower”) and AGSTAR
FINANCIAL SERVICES, PCA (“Lender”).



RECITALS




     A. Borrower previously executed and delivered to the Lender a Term Revolving Note in the
original principal amount of $17,000,000.00, dated February 26, 2007 (the “Note”) to which this
Allonge is attached.



     B. Borrower has requested that Lender amend certain terms of the Note; and, Lender is willing
to make such modifications to the terms of the Note, all in accordance with the terms and
conditions of this Allonge.



AGREEMENT




     NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants contained
in this Allonge and for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged by Borrower and Lender, the parties agree as follows:



     1. Modification of Note. Notwithstanding any of the provisions of that certain Master
Loan Agreement dated as of November 15, 2005, as amended by that certain Amendment No.1 and Waiver
to Master Loan Agreement dated as of July 31, 2006, and by that certain Amended and Restated Master
Loan Agreement dated as of February 26, 2007, and by that certain Amendment No. 1 to Amended and
Restated Master Loan Agreement dated October 19, 2007 (as amended, the “MLA”); or that certain
Fourth Supplement to the Master Loan Agreement dated as of February 26, 2007, as amended by that
certain Amendment No. 1 to Fourth Supplement to the Master Loan Agreement effective as of October
19, 2007 (as amended, the “Fourth Supplement”), section 7 of the Note is deleted in its entirety.



     2. Remaining Terms. All other terms and provisions of the Note shall remain in full
force and effect, enforceable by Lender against Borrower as fully as though no amendments had been
made hereby, and this Allonge shall not be deemed to hinder, compromise or lessen the
enforceability of the Note, or any mortgage, security interest, guaranty or other Loan Document
securing repayment of the Note, in any way.



     IN WITNESS WHEREOF, the parties hereto have caused this Allonge to be duly executed and
delivered as of the date and year first above written.



BORROWER:




	 	 	 
	US BIO ALBERT CITY, LLC,

an Iowa limited liability company
	 	 
	 
	 	 
	/s/ Kelly S. Langley
 

By: Kelly S. Langley

	 	 
	Its: Treasurer
#### STATE ex rel. Rodney SHERMAN v. STATE of Louisiana.

No. 97-KH-3077.

Supreme Court of Louisiana.

May 15, 1998.

In re Sherman, Rodney; — Plaintiff(s); applying for supervisory and/or remedial writs; Parish of Orleans, Criminal District Court, Div. “F”, No. 331-137; to the Court of Appeal, Fourth Circuit, No. 96KW-0545.

Denied.

TRAYLOR, J., not on panel.
```

[Federal Register Volume 80, Number 20 (Friday, January 30, 2015)]
[Notices]
[Page 5097]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01761]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army; Corps of Engineers

Notice of Availability of the Draft Environmental Impact 
Statement (DEIS) for the Installation of a Terminal Groin Structure at 
the Eastern End of Ocean Isle Beach, Extending Into the Atlantic Ocean, 
West of Shallotte Inlet (Brunswick County, NC)

AGENCY: Department of the Army, U.S. Army Corps of Engineers, DoD.

ACTION: Changes to public hearing and comment period end dates.

-----------------------------------------------------------------------

SUMMARY: The comment period for the DEIS published in the Federal 
Register on January 23, 2015, required comments be submitted on or 
before March 9, 2015. The DEIS comment period has been changed to March 
16, 2015. Additionally, the Public Hearing date has been changed to 
March 3, 2015.

FOR FURTHER INFORMATION CONTACT: Questions about the proposed action 
and DEIS can be directed to Mr. Tyler Crumbley, Wilmington Regulatory 
Field Office, telephone: (910) 251-4170, facsimile (910) 251-4025, or 
email at tyler.crumbley@usace.army.mil.

SUPPLEMENTARY INFORMATION: None.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2015-01761 Filed 1-29-15; 8:45 am]
BILLING CODE 3720-58-P
```
No. 46493.

#### Protests 63200-K, etc., of Dezell & Co. et al. (New York).

Opinion by

Cline, J.

In accordance with stipulation of counsel and following *Bullocks*v. *United States*(6 Cust. Ct. 110, C. D. 441) articles (not fabrics) were held not subject to countervailing duty as claimed.
**EXHIBIT
      32.2**


**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of Pingchuan Pharmaceutical, Inc. (the
      "Registrant") on Form 10-QSB for the period ended June 30, 2005 as filed with
      the Securities and Exchange Commission on the date hereof (the "Report"), I,
      Zhang, Chunman, Chief Financial Officer of the Registrant, certifies, pursuant
      to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of
      2002,
      that, based on my knowledge:





(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.





PINGCHUAN
      PHARMACEUTICAL, INC.








/s/
      ZHANG, CHUNMAN


Date:
      August 19,
      2005 ZHANG,
      CHUNMAN


CHIEF
      FINANCIAL OFFICER
<PAGE>
                                  Exhibit 23.1



CONSENT OF INDEPENDENT AUDITORS



We consent to the incorporation by reference in the Registration Statement on
Form S-8 (No. 33-50508) pertaining to the Maxicare Health Plans, Inc. 1990 Stock
Option Plan, the stock option agreement with Peter J. Ratican dated December 5,
1990, and the stock option agreement with Eugene L. Froelich dated December 5,
1990; the incorporation by reference in the Registration Statement on Form S-8
(No. 333-12803) pertaining to the Maxicare Health Plans, Inc. Outside Directors
1996 Formula Stock Option Plan, the Maxicare Health Plans, Inc. Senior
Executives 1996 Stock Option Plan, the Maxicare Health Plans, Inc. 1995 Stock
Option Plan, the Restricted Stock Grant Agreement by and between Maxicare Health
Plans, Inc. and Peter J. Ratican dated as of February 27, 1995, the Restricted
Stock Grant Agreement by and between Maxicare Health Plans, Inc. and Eugene L.
Froelich dated as of February 27, 1995; the incorporation by reference in the
Registration Statement on Form S-8 (No. 333-88005) pertaining to the Maxicare
Health Plans, Inc. 1999 Stock Option Plan; and the incorporation by reference in
the Registration Statement on Form S-3 (No. 333-48458) and the incorporation by
reference in the Registration Statement on Form S-2 (No. 333-41510) of our
report dated March 22, 2002 with respect to the 2001 consolidated financial
statements and schedule of Maxicare Health Plans, Inc. in its annual report on
Form 10-K for the year ended December 31, 2001.
**EXHIBIT32.02**

 

**CERTIFICATIONPURSUANT TO**

**18U.S.C. SECTION 1350,**

**ASADOPTED PURSUANT TO**

**SECTION 906OF THE SARBANES-OXLEY ACT OF 2002**

 

Inconnection with the Quarterly Report of PDF Solutions, Inc. (“the Company”)on Form 10-Q for the quarter ended June 30, 2009 as filed with theSecurities and Exchange Commission on August 10, 2009 (“the Report”), I,Keith A. Jones, Chief Financial Officer and Vice President of Finance of theCompany, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuantto Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1) TheReport fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

(2) Theinformation contained in the Report fairly presents, in all material respects,the financial condition and result of operations of the Company.

 
|                        | /s/ KEITH A.  JONES                                      |
|-----------------------------|----------------------------------------------------------|
|                        | Keith A. Jones                                           |
|                        | *Chief  Financial Officer and Vice President of Finance* |
|                        | *(Principal  Financial**Officer)*                        |
|                        |                                                     |
| Date:  August 10, 2009 |                                                     |

 

----
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access topublications in the archive is available through GPO's suite of cataloging andlocator services, including the Catalog of U.S. Government Publications(CGP).  Archived copies of publications are retrieved in the event thatpublications are no longer available from the original publishing agency site. 
**Title:****Occupational injuries andillnesses--counts, rates, and characteristics [electronic resource]**
 
2004| 2005| 2006
 
SuDoc Number:L 2.3/11:
Item Number:0768-A-03 (online)
CGP systemNumber:000664227
 
January 10, 2020
No. 55500.

#### Bohemian Distributing Co. et al. *v.*United States,

protests 114385-K, etc. (Los Angeles).

Opinion by

Johnson, J.

Following the authorities cited in Abstract 15400 the court dismissed the protests.
[Federal Register Volume 62, Number 147 (Thursday, July 31, 1997)]
[Notices]
[Pages 41051-41052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20136]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Announcement Number 789]


Research and Demonstration Programs in Surveillance, Prevention, 
and Control of Healthcare-Associated Infections and Antimicrobial 
Resistant Infections

Amendment

    A notice announcing the availability of fiscal year (FY) 1997 funds 
for cooperative agreements for Research and Demonstration Programs in 
Surveillance, Prevention, and Control of Healthcare-Associated 
Infections and

[[Page 41052]]

Antimicrobial Resistant Infections was published in the Federal 
Register on July 8, 1997, (62 FR 36541). The notice is amended as 
follows:
    On page 36543, under the heading ``Specific Instructions,'' second 
column, 4. Objectives and Technical Approach, lines three and four have 
been changed and should read: ``Recipient Activities (A.1.a., A.1.b., 
A.2., A.3., and A.4.). . . .''
    On page 36544, second column, third paragraph, c., line six should 
read ``Activities A.4.). . . .''
    All other information and requirements of the July 8, 1997, Federal 
Register notice remain the same.

    Dated: July 25, 1997.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-20136 Filed 7-30-97; 8:45 am]
BILLING CODE 4163-18-P
Case No. 10,102.

#### NELSON v. BOWEN.

[Nowhere reported; opinion not now accessible.]
No. 39246.

#### Protest 381501-G of Gimbel Bros., Inc. (New York).

Opinion by

Dallinger, J.

In accordance with stipulation of counsel atomizers, atomizers and droppers, sprays, boxes, vases, trays, sugar, creamer, salt and pepper shakers, incense burners, candlestick, and crumb sets chiefly used in the kitchen or household or on the table for utilitarian purposes or hollow ware were held dutiable at 40 percent under paragraph 339.
II 

112TH CONGRESS 

2D SESSION S. 2251 

To designate the United States courthouse located at 709 West 9th Street, 

Juneau, Alaska, as the Robert Boochever United States Courthouse. 

IN THE SENATE OF THE UNITED STATES 

MARCH 29, 2012 

Mr. BEGICH (for himself and Ms. MURKOWSKI) introduced the following bill; 

which was read twice and referred to the Committee on Environment and 

Public Works 

A BILL 

To designate the United States courthouse located at 709 

West 9th Street, Juneau, Alaska, as the Robert 

Boochever United States Courthouse. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ROBERT BOOCHEVER UNITED STATES COURT4 HOUSE. 

5 (a) DESIGNATION.—The United States courthouse 

6 located at 709 West 9th Street, Juneau, Alaska, shall be 

7 known and designated as the ‘‘Robert Boochever United 

8 States Courthouse’’. 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 2251 IS

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the United States courthouse referred to in sub4 section (a) shall be deemed to be a reference to the ‘‘Rob5 ert Boochever United States Courthouse’’. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS
EXHIBIT 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Memry Corporation (the Company) on Form 10-K for the fiscal year ended June 30, 2004 as filed with the Securities and
Exchange Commission on September 28, 2004 (the Report), I, Robert P. Belcher, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:



(1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                         
|-----------------------------------------
|                                         
|/s/ Robert P. Belcher                    
|Robert P. Belcher Chief Financial Officer



Dated: September 28, 2004



This certification is made solely for the purpose of 18 U.S.C. Section 1350, subject to
the knowledge standard contained therein, and not for any other purpose.
No. 74-1008.

#### Bacon et al. *v.*Texaco Inc.

C. A. 5th Cir. Certiorari denied.
EXHIBIT
      32.2








**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**








In
      connection with the Quarterly Report of nFinanSe Inc. (the “Company”) on Form
      10-QSB for the period ended June 30, 2007, as filed with the Securities and
      Exchange Commission on the date hereof (the “Report”), I, Raymond P. Springer,
      in my capacity as Chief Financial Officer of the Company, certify, pursuant
      to
      18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
      of
      2002, that:





The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





***/s/
                Raymond P. Springer***Date:   August
                14, 2007
            Raymond
                P. Springer
              Chief
                Financial Officer
```

[Federal Register Volume 78, Number 208 (Monday, October 28, 2013)]
[Notices]
[Page 64211]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25572]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2013-0490; FRL-9902-06]

FIFRA Scientific Advisory Panel; Notice of Cancellation

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency is issuing this notice to cancel the 3-day meeting 
of the Federal Insecticide, Fungicide, and Rodenticide Act Scientific 
Advisory Panel (FIFRA SAP) to consider and review scientific 
uncertainties associated with corn rootworm resistance monitoring for 
Bt corn Plant Incorporated Protectants (PIPs) scheduled for October 
30--November 1, 2013. The meeting was announced in the Federal Register 
on August 9, 2013. The meeting will be rescheduled.

FOR FURTHER INFORMATION CONTACT: Fred Jenkins, DFO, Office of Science 
Coordination and Policy (7201M), Environmental Protection Agency, 1200 
Pennsylvania Ave. NW., Washington, DC 20460-0001; telephone number: 
(202) 564-3327; fax number: (202) 564-8382; email address: 
jenkins.fred@epa.gov.

SUPPLEMENTARY INFORMATION: The meeting was announced in the Federal 
Register on August 9, 2013 (78 FR 48672, FRL-9394-3). This meeting will 
be rescheduled in the near future and announced in the Federal 
Register.

List of Subjects

    Environmental protection, Pesticides and pests.

    Dated: October 23, 2013.
David Dix,
Director, Office of Science Coordination and Policy.
[FR Doc. 2013-25572 Filed 10-24-13; 4:15 pm]
BILLING CODE 6560-50-P
```
No. 47762.

#### Protest 24416-K of W. J. Green (New York).

Opinion by

Kincheloe, J.

In accordance with stipulation of counsel that the flax waste in question is used chiefly for paper making and that it is the same in all material respects as that the subject of *Green*v. *United States*(8 Cust. Ct. 173, C. D 599), the claim for free entry under paragraph 1750 was sustained.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                         131,090
<INT-BEARING-DEPOSITS>                             697
<FED-FUNDS-SOLD>                                92,752
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    355,324
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                      1,799,209
<ALLOWANCE>                                     26,743
<TOTAL-ASSETS>                               2,585,880
<DEPOSITS>                                   2,172,269
<SHORT-TERM>                                     5,259
<LIABILITIES-OTHER>                             37,814
<LONG-TERM>                                     18,463
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       351,422
<OTHER-SE>                                         653
<TOTAL-LIABILITIES-AND-EQUITY>               2,585,880
<INTEREST-LOAN>                                151,483
<INTEREST-INVEST>                               18,572
<INTEREST-OTHER>                                11,573
<INTEREST-TOTAL>                               181,628
<INTEREST-DEPOSIT>                              46,219
<INTEREST-EXPENSE>                              48,520
<INTEREST-INCOME-NET>                          133,108
<LOAN-LOSSES>                                    1,325
<SECURITIES-GAINS>                               1,550
<EXPENSE-OTHER>                                130,150
<INCOME-PRETAX>                                 46,489
<INCOME-PRE-EXTRAORDINARY>                      20,156
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    20,156
<EPS-PRIMARY>                                     1.00
<EPS-DILUTED>                                      .98
<YIELD-ACTUAL>                                    6.16
<LOANS-NON>                                     14,929
<LOANS-PAST>                                     1,007
<LOANS-TROUBLED>                                 6,902
<LOANS-PROBLEM>                                 23,874
<ALLOWANCE-OPEN>                                20,271
<CHARGE-OFFS>                                    7,211
<RECOVERIES>                                     3,701
<ALLOWANCE-CLOSE>                               26,743
<ALLOWANCE-DOMESTIC>                            26,743
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>